202 related articles for article (PubMed ID: 2227542)
1. Treatment of 29 patients with bulky squamous cell carcinoma of the cervix with simultaneous cisplatin, 5-fluorouracil, and split-course hyperfractionated radiation therapy.
Heaton D; Yordan E; Reddy S; Bonomi P; Lee MS; Lincoln S; Graham J; Dolan T; Miller A; Phillips A
Gynecol Oncol; 1990 Sep; 38(3):323-7. PubMed ID: 2227542
[TBL] [Abstract][Full Text] [Related]
2. Treatment of carcinoma of the uterine cervix with concomitant cisplatin, 5-fluorouracil and split course hyperfractionated radiotherapy.
Tubiana-Mathieu N; Bonnier P; Delaby F; Murraciole X; Lejeune C; Hadjadj DJ; Juin P; Piana L
Eur J Obstet Gynecol Reprod Biol; 1998 Mar; 77(1):95-100. PubMed ID: 9550208
[TBL] [Abstract][Full Text] [Related]
3. Phase I-II study of combined 5-fluorouracil and cisplatin chemotherapy and altered fractionation radiotherapy for advanced squamous cell carcinoma of the cervix.
Fishman A; Chiu JK; Girtanner RE; Dennis W; Carpenter LS; Lu HH; Woo SY; Kerley JM; Kaplan AL
Am J Clin Oncol; 1997 Aug; 20(4):342-7. PubMed ID: 9256886
[TBL] [Abstract][Full Text] [Related]
4. High complete response rate of concomitant chemoradiotherapy for locally advanced squamous cell carcinoma of the uterine cervix.
Lin JC; Ho ES; Jan JS; Yang CH; Liu FS
Gynecol Oncol; 1996 Apr; 61(1):101-8. PubMed ID: 8626094
[TBL] [Abstract][Full Text] [Related]
5. Mature results of a pilot study of pelvic radiotherapy with concurrent continuous infusion intra-arterial 5-FU for stage IIIB-IVA squamous cell carcinoma of the cervix.
Chaney AW; Eifel PJ; Logsdon MD; Morris M; Wharton JT
Int J Radiat Oncol Biol Phys; 1999 Aug; 45(1):113-8. PubMed ID: 10477014
[TBL] [Abstract][Full Text] [Related]
6. Hyperfractionated radiation therapy and concurrent 5-fluorouracil, cisplatin and mitomycin-C in head and neck carcinoma. A pilot study.
Abitbol AA; Schwade JG; Lewin AA; Sridhar K; Brandon AH; Markoe AM; Casiano RR; Houdek PV; Serago C; Miller DJ
Am J Clin Oncol; 1992 Jun; 15(3):250-5. PubMed ID: 1590280
[TBL] [Abstract][Full Text] [Related]
7. Twice-daily fractionation of external irradiation with brachytherapy and chemotherapy in carcinoma of the cervix with positive para-aortic lymph nodes: Phase II study of the Radiation Therapy Oncology Group 92-10.
Grigsby PW; Lu JD; Mutch DG; Kim RY; Eifel PJ
Int J Radiat Oncol Biol Phys; 1998 Jul; 41(4):817-22. PubMed ID: 9652843
[TBL] [Abstract][Full Text] [Related]
8. Preliminary results of concurrent radiotherapy and chemotherapy with cis-platinum, vincristine, and bleomycin in bulky, advanced cervical carcinoma: a pilot study.
Chang HC; Lai CH; Chen MS; Chao AS; Chen LH; Soong YK
Gynecol Oncol; 1992 Feb; 44(2):182-8. PubMed ID: 1371978
[TBL] [Abstract][Full Text] [Related]
9. Mature results of a phase II trial of concomitant cisplatin/pelvic radiotherapy for locally advanced squamous cell carcinoma of the cervix.
Fields AL; Anderson PS; Goldberg GL; Wadler S; Beitler J; Sood B; Runowicz CD
Gynecol Oncol; 1996 Jun; 61(3):416-22. PubMed ID: 8641625
[TBL] [Abstract][Full Text] [Related]
10. Phase II study of tolerance and efficacy of hyperfractionated radiotherapy and 5-fluorouracil, cisplatin, and paclitaxel (Taxol) in stage III and IV inoperable and/or unresectable head-and-neck squamous cell carcinoma: A-2 protocol.
Abitbol A; Abdel-Wahab M; Lewin A; Troner M; Rodrigues MA; Hamilton-Nelson KL; Markoe A
Int J Radiat Oncol Biol Phys; 2002 Jul; 53(4):942-7. PubMed ID: 12095561
[TBL] [Abstract][Full Text] [Related]
11. Continuous infusion of low-dose 5-fluorouracil and radiation therapy for poor-prognosis squamous cell carcinoma of the uterine cervix.
Drescher CW; Reid GC; Terada K; Roberts JA; Hopkins MP; Perez-Tamayo C; Schoeppel SL
Gynecol Oncol; 1992 Mar; 44(3):227-30. PubMed ID: 1541433
[TBL] [Abstract][Full Text] [Related]
12. Induction chemotherapy followed by concurrent chemoradiation in advanced squamous cell carcinoma of the head and neck: final results from a phase II study with docetaxel, cisplatin and 5-fluorouracil with a four-year follow-up.
Rapidis AD; Trichas M; Stavrinidis E; Roupakia A; Ioannidou G; Kritselis G; Liossi P; Giannakouras G; Douzinas EE; Katsilieris I
Oral Oncol; 2006 Aug; 42(7):675-84. PubMed ID: 16731029
[TBL] [Abstract][Full Text] [Related]
13. Concurrent cisplatin and 5-fluorouracil chemotherapy and radiation therapy for advanced-stage squamous carcinoma of the vulva.
Berek JS; Heaps JM; Fu YS; Juillard GJ; Hacker NF
Gynecol Oncol; 1991 Sep; 42(3):197-201. PubMed ID: 1955180
[TBL] [Abstract][Full Text] [Related]
14. A feasibility study of 252Cf neutron brachytherapy, cisplatin + 5-FU chemo-adjuvant and accelerated hyperfractionated radiotherapy for advanced cervical cancer.
Maruyama Y; Bowen MG; Van Nagell JR; Gallion HH; DePriest P; Wierzbicki J
Int J Radiat Oncol Biol Phys; 1994 Jun; 29(3):529-34. PubMed ID: 8005811
[TBL] [Abstract][Full Text] [Related]
15. Concurrent radiation, mitomycin C and 5-fluorouracil in poor prognosis carcinoma of cervix: preliminary results of a phase I-II study.
Thomas G; Dembo A; Beale F; Bean H; Bush R; Herman J; Pringle J; Rawlings G; Sturgeon J; Fine S
Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1785-90. PubMed ID: 6434500
[TBL] [Abstract][Full Text] [Related]
16. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
[TBL] [Abstract][Full Text] [Related]
17. A retrospective review of 15 years of radical radiotherapy with or without concurrent cisplatin and/or 5-fluorouracil for the treatment of locally advanced cervical cancer.
Borowsky ME; Elliott KS; Pezzullo JC; Santoso P; Choi W; Choi K; Abulafia O
Bull Cancer; 2005 Feb; 92(2):E19-24. PubMed ID: 15749639
[TBL] [Abstract][Full Text] [Related]
18. Phase I/II study of definitive radiotherapy and chemotherapy (cisplatin and 5-fluorouracil) for advanced or recurrent gynecologic malignancies. Preliminary report.
Kuske RR; Perez CA; Grigsby PW; Lovett RD; Jacobs AJ; Galakatos AE; Camel HM; Kao MS
Am J Clin Oncol; 1989 Dec; 12(6):467-73. PubMed ID: 2686392
[TBL] [Abstract][Full Text] [Related]
19. Phase I trial of concurrent hyperfractionated split course radiotherapy (HFx RT), cisplatin (cDDP), and paclitaxel in patients with recurrent, previously irradiated, or treatment-naïve locally advanced upper aerodigestive malignancy.
Langer CJ; Duffy K; Horwitz EM; Litwin S; Rosvold E; Schol J; Keenan E; Nicolaou N; Friedman CD; Ridge JA
Cancer Invest; 2006 Mar; 24(2):164-73. PubMed ID: 16537186
[TBL] [Abstract][Full Text] [Related]
20. Intra-arterial infusion chemotherapy using cisplatin with radiotherapy for Stage III squamous cell carcinoma of the cervix.
Kaneyasu Y; Nagai N; Nagata Y; Hashimoto Y; Yuki S; Murakami Y; Kenjo M; Kakizawa H; Toyota N; Fujiwara H; Kudo Y; Ito K
Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):369-77. PubMed ID: 19735865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
